Multinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the Ahmedabad company’s US sales was lifted. “Pfizer has terminated its supply agreement and has no current plans to source any products from Claris,” a Pfizer spokesperson said in response to an email query. Claris did not respond to ET’s email, but one person in the know of the development said, Pfizer lost two crucial years when the ban was in force and did not see any major business coming from generic injectables made by Claris.
